The University of California-San Francisco is collaborating with the University of California, Berkeley to offer a two-year master's degree in "translational medicine," the discipline of transferring lab breakthroughs to the marketplace. The MBA-style program will target students from both medical and high-tech fields. The program begins this fall.
